Scarica l'app Stockscreener
1.16
2.65%
0.03
Dopo l'orario di chiusura:
1.16
Precedente Chiudi:
$1.13
Aprire:
$1.12
Volume 24 ore:
1.44M
Relative Volume:
0.22
Capitalizzazione di mercato:
$25.98M
Reddito:
-
Utile/perdita netta:
$-16.28M
Rapporto P/E:
-0.0834
EPS:
-13.91
Flusso di cassa netto:
$-13.75M
1 W Prestazione:
+2.65%
1M Prestazione:
+61.58%
6M Prestazione:
+47.58%
1 anno Prestazione:
-56.23%
Intervallo 1D:
$1.11
$1.32
Intervallo di 1 settimana:
$1.09
$1.32
Portata 52W:
$0.281
$3.85
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Nome
Pasithea Therapeutics Corp
Settore
Industria
Telefono
(702) 514-4174
Indirizzo
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Confronta KTTA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
1.16 | 25.31M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pasithea Therapeutics Corp Borsa (KTTA) Ultime notizie
Pasithea Therapeutics regains Nasdaq compliance - MSN
Pasithea Therapeutics regains Nasdaq compliance with minimum bid price rule - Investing.com
Pasithea Therapeutics Regains Nasdaq Compliance - TipRanks
Market Review: Is Pasithea Therapeutics Corp stock a contrarian buy2025 Top Gainers & Safe Capital Allocation Plans - moha.gov.vn
SCHNEIDERMAN DANIEL H Insider Trades - Nasdaq
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Pasithea Therapeutics Corp - GuruFocus
Pasithea Therapeutics (NASDAQ:KTTA) Upgraded at Zacks Research - Defense World
Pasithea Therapeutics Corp. (KTTA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Did KTTA Stock Soar A Whopping 48% Today? - MSN
What is HC Wainwright’s Forecast for KTTA FY2025 Earnings? - Defense World
HC Wainwright Begins Coverage on Pasithea Therapeutics (NASDAQ:KTTA) - Defense World
There is no way Pasithea Therapeutics Corp (KTTA) can keep these numbers up - setenews.com
Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright By Investing.com - Investing.com Nigeria
HC Wainwright & Co. Initiates Coverage of Pasithea Therapeutics (KTTA) with Buy Recommendation - Nasdaq
Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright - Investing.com
HC Wainwright Initiates Coverage on Pasithea Therapeutics With Buy Rating, $3 Price Target - marketscreener.com
MSN Money - MSN
Is Pasithea Therapeutics Corp. stock attractive for hedge funds2025 Top Decliners & Technical Confirmation Trade Alerts - Newser
Small Cap Stocks To ConsiderNovember 30th - MarketBeat
Will Pasithea Therapeutics Corp. Equity Warrant stock benefit from commodity prices2025 Dividend Review & Weekly Top Performers Watchlists - Newser
Insiders Buying Pasithea Therapeutics Might Wish They Invested More, Stock Gains 10% - Yahoo Finance
Pasithea Therapeutics Reaches US$104m Market Cap Benefiting Insider Stock Buying - simplywall.st
Lawrence Steinman Bought 201% More Shares In Pasithea Therapeutics - Yahoo Finance
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Top Biotech Stocks To Watch TodayNovember 29th - MarketBeat
Small Cap Stocks To Follow NowNovember 29th - MarketBeat
Best Small Cap Stocks To Keep An Eye OnNovember 28th - MarketBeat
Pasithea Therapeutics Completes $60M Public Offering - TipRanks
Best Penny Stocks To Watch TodayNovember 29th - MarketBeat
Pasithea Therapeutics announces closing of $60 million public offering of common stock - marketscreener.com
Pasithea Therapeutics (Nasdaq: KTTA) raises $60M, extends cash runway into 2028 - Stock Titan
Promising Penny Stocks To Consider – November 30th - Defense World
Small Cap Stocks To Consider – November 30th - Defense World
Published on: 2025-12-02 03:15:38 - Newser
Biotech Stocks To Watch Today – November 30th - Defense World
Pasithea Therapeutics (KTTA) Stock Analysis Report | Financials & Insights - Benzinga
Insider Buying Spree at Pasithea Therapeutics: Top Executives Invest Big! - TipRanks
Biotech Stocks To Watch TodayNovember 30th - MarketBeat
Pasithea Therapeutics Stock (KTTA) Opinions on PAS-004 Drug Updates - Quiver Quantitative
Pasithea therapeutics (KTTA) director Steinman buys $99,999 in stock By Investing.com - Investing.com Canada
Dumesnil Simon buys Pasithea Therapeutics (KTTA) shares By Investing.com - Investing.com Canada
Marques buys Pasithea Therapeutics (KTTA) shares worth $24999 By Investing.com - Investing.com Canada
Pasithea therapeutics (KTTA) director Steinman buys $99,999 in stock - Investing.com India
Dumesnil Simon buys Pasithea Therapeutics (KTTA) shares - Investing.com
Marques buys Pasithea Therapeutics (KTTA) shares worth $24999 - Investing.com
Pasithea Therapeutics Executives and Directors Make Significant Stock Purchases - TradingView — Track All Markets
Pasithea Therapeutics Corp Azioni (KTTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):